CareDx Inc (CDNA) Shares Sold by Gagnon Securities LLC
Gagnon Securities LLC trimmed its position in shares of CareDx Inc (NASDAQ:CDNA) by 13.3% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,878,746 shares of the company’s stock after selling 287,657 shares during the period. CareDx accounts for approximately 4.9% of Gagnon Securities LLC’s holdings, making the stock its 3rd biggest position. Gagnon Securities LLC owned approximately 0.07% of CareDx worth $13,790,000 at the end of the most recent quarter.
Other institutional investors have also recently bought and sold shares of the company. FNY Partners Fund LP acquired a new position in CareDx during the 4th quarter valued at about $102,000. Cambridge Investment Research Advisors Inc. acquired a new position in CareDx during the 3rd quarter valued at about $106,000. Wells Fargo & Company MN boosted its stake in CareDx by 1,360.6% during the 4th quarter. Wells Fargo & Company MN now owns 16,636 shares of the company’s stock valued at $122,000 after purchasing an additional 15,497 shares during the period. Bank of Montreal Can acquired a new position in CareDx during the 4th quarter valued at about $130,000. Finally, BlackRock Inc. boosted its stake in CareDx by 386.0% during the 4th quarter. BlackRock Inc. now owns 34,480 shares of the company’s stock valued at $253,000 after purchasing an additional 27,385 shares during the period. 39.67% of the stock is owned by hedge funds and other institutional investors.
In other CareDx news, insider James P. Yee sold 29,197 shares of the business’s stock in a transaction dated Friday, December 8th. The shares were sold at an average price of $7.00, for a total transaction of $204,379.00. Following the sale, the insider now directly owns 74,795 shares in the company, valued at approximately $523,565. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 5.40% of the stock is currently owned by insiders.
Shares of CareDx Inc (NASDAQ:CDNA) opened at $5.86 on Friday. CareDx Inc has a 52-week low of $0.76 and a 52-week high of $7.98. The company has a market cap of $171.12, a PE ratio of -3.24 and a beta of 0.72. The company has a debt-to-equity ratio of -124.53, a quick ratio of 0.35 and a current ratio of 0.55.
CareDx, Inc is a molecular diagnostics company. The Company is focused on the discovery, development and commercialization of clinically differentiated diagnostic surveillance solutions for transplant patients. The Company’s commercialized testing solution, the AlloMap heart transplant molecular test (AlloMap), is a gene expression test that helps clinicians monitor and identify heart transplant recipients with stable graft function having a low probability of moderate/severe acute cellular rejection.
Want to see what other hedge funds are holding CDNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CareDx Inc (NASDAQ:CDNA).
Receive News & Ratings for CareDx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CareDx and related companies with MarketBeat.com's FREE daily email newsletter.